merck revenue

Drugmaker Merck & Co. (MRK) said Thursday it lost $531 million in the fourth quarter due to nearly $4 billion charges, including writeoffs and restructuring costs from its acquisition of Schering-Plough Corp. in 2009. Almost half of the charges were to account for diminished prospects for...

The pharmaceutical giant said its profit was impacted by a large charge related to its recent merger with Schering-Plough, but still managed to top analyst estimates. Looking forward, Merck lifted the lower end of its 2010 earnings guidance.

Pharmaceutical giant Merck & Co. reported Friday its second-quarter net income fell 51% on higher restructuring and merger costs. But adjusted earnings beat analysts' estimates.